Burns Matteson Capital Management LLC Purchases New Position in UnitedHealth Group Incorporated $UNH

Burns Matteson Capital Management LLC acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 3rd quarter, Holdings Channel reports. The firm acquired 8,017 shares of the healthcare conglomerate’s stock, valued at approximately $2,768,000. UnitedHealth Group makes up 0.9% of Burns Matteson Capital Management LLC’s holdings, making the stock its 23rd biggest holding.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Murphy Pohlad Asset Management LLC raised its position in shares of UnitedHealth Group by 21.8% in the 2nd quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate’s stock worth $1,380,000 after purchasing an additional 791 shares during the last quarter. Berkshire Hathaway Inc bought a new position in shares of UnitedHealth Group in the second quarter worth approximately $1,572,193,000. Triumph Capital Management bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $1,324,000. Wealth Effects LLC lifted its position in UnitedHealth Group by 14.4% in the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after acquiring an additional 591 shares in the last quarter. Finally, IFP Advisors Inc increased its holdings in shares of UnitedHealth Group by 20.7% in the 2nd quarter. IFP Advisors Inc now owns 20,683 shares of the healthcare conglomerate’s stock worth $6,462,000 after purchasing an additional 3,545 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.3%

NYSE UNH opened at $331.76 on Friday. The stock’s 50-day moving average price is $333.71 and its 200-day moving average price is $318.99. The company has a market capitalization of $300.52 billion, a P/E ratio of 17.32, a price-to-earnings-growth ratio of 2.13 and a beta of 0.43. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm’s revenue was up 12.2% compared to the same quarter last year. During the same quarter last year, the business earned $7.15 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Barclays increased their price objective on UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. The Goldman Sachs Group began coverage on shares of UnitedHealth Group in a research note on Tuesday, October 14th. They issued a “buy” rating and a $406.00 price target for the company. JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Jefferies Financial Group increased their price target on UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a report on Friday, October 17th. Finally, Leerink Partners set a $410.00 price objective on UnitedHealth Group and gave the company an “outperform” rating in a research report on Wednesday, October 29th. Seventeen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Hold” and a consensus price target of $385.54.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.